跳至主要内容
临床试验/JPRN-UMIN000003445
JPRN-UMIN000003445已完成未知

The study on the effectiveness of protease inhibitors for patients with refractory urticaria - The effectiveness of protease inhibitors for patients with urticaria

Department of Dermatology, Programs for Biomedical Research, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University0 个研究点目标入组 10 人开始时间: 2010年4月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnant or lactating women or women of child bearing potential not using contraception 2. Patients with diseases as follows. Liver disease, psychological illness, convulsive and other seizure, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes, and autoimmune diseases. 3. Patients who use medications that influence the coagulation and fibrinolytic cascade. 4. Patients who were administered nafamostat mesilate and camostat mesilate with serious adverse events. 5. Patients in contraindication of nafamostat mesilate and camostat mesilate. 6. Others who the physician judges are not suitable as subjects

研究者

发起方
Department of Dermatology, Programs for Biomedical Research, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University

相似试验